3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
3
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Breast Neoplasms
1
Interventions
venetoclax
26
Azacitidine
24
fludarabine
11
Cytarabine
11
Specimen Handling
9
Biopsy
7
Busulfan
6
Melphalan
5
Decitabine
5
Daunorubicin
5
Thiotepa
4
Cyclophosphamide
4
selinexor
3
olutasidenib
3
gilteritinib
3
Whole-Body Irradiation
3
Tacrolimus
3
Idarubicin
3
Homoharringtonine
3
treosulfan
2
revumenib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Stem Cell Transplantation
2
Maintenance
2
Lymphatic Irradiation
2
Leukapheresis
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Drug Therapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Leukemia, Myeloid, Acute
×
talazoparib
×
Clear all
NCT05319249
2024-04-05
NAKIP-AML
German Cancer Research Center
Phase 1/2
Not yet recruiting
54 enrolled